BCTX
Price
$2.91
Change
-$0.02 (-0.68%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
19.87M
KNTPF
Price
$0.18
Change
-$0.03 (-14.29%)
Updated
Apr 7 closing price
Capitalization
82.91M
Interact to see
Advertisement

BCTX vs KNTPF

Header iconBCTX vs KNTPF Comparison
Open Charts BCTX vs KNTPFBanner chart's image
Briacell Therapeutics Corp NEW
Price$2.91
Change-$0.02 (-0.68%)
Volume$825
Capitalization19.87M
KINTOR PHARMACEUTICAL
Price$0.18
Change-$0.03 (-14.29%)
Volume$750
Capitalization82.91M
BCTX vs KNTPF Comparison Chart in %
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. KNTPF commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Hold and KNTPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (BCTX: $2.94 vs. KNTPF: $0.18)
Brand notoriety: BCTX and KNTPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 35% vs. KNTPF: 100%
Market capitalization -- BCTX: $19.87M vs. KNTPF: $82.91M
BCTX [@Biotechnology] is valued at $19.87M. KNTPF’s [@Biotechnology] market capitalization is $82.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whileKNTPF’s FA Score has 0 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • KNTPF’s FA Score: 0 green, 5 red.
According to our system of comparison, KNTPF is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 4 TA indicator(s) are bullish while KNTPF’s TA Score has 2 bullish TA indicator(s).

  • BCTX’s TA Score: 4 bullish, 4 bearish.
  • KNTPF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, KNTPF is a better buy in the short-term than BCTX.

Price Growth

BCTX (@Biotechnology) experienced а +0.34% price change this week, while KNTPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.91%. For the same industry, the average monthly price growth was +33.07%, and the average quarterly price growth was +3.79%.

Reported Earning Dates

BCTX is expected to report earnings on Jun 16, 2025.

Industries' Descriptions

@Biotechnology (+6.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($82.9M) has a higher market cap than BCTX($19.9M). KNTPF YTD gains are higher at: 10.875 vs. BCTX (-65.310).
BCTXKNTPFBCTX / KNTPF
Capitalization19.9M82.9M24%
EBITDA-27.19MN/A-
Gain YTD-65.31010.875-601%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash5.01MN/A-
Total Debt27KN/A-
FUNDAMENTALS RATINGS
BCTX: Fundamental Ratings
BCTX
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCTXKNTPF
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
33%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend 22 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRAR1.330.04
+3.10%
Glimpse Group (The)
LYB62.561.36
+2.22%
LyondellBasell Industries NV
CWAN21.77-0.12
-0.55%
Clearwater Analytics Holdings
HFFG3.25-0.05
-1.52%
HF Foods Group
METC12.02-1.12
-8.52%
Ramaco Resources

BCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCTX has been loosely correlated with KROS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BCTX jumps, then KROS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
+2.80%
KROS - BCTX
34%
Loosely correlated
+0.45%
MDGL - BCTX
30%
Poorly correlated
-0.00%
AXON - BCTX
30%
Poorly correlated
-0.09%
LSB - BCTX
30%
Poorly correlated
-2.86%
VKTX - BCTX
29%
Poorly correlated
+3.94%
More

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and MLEC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and MLEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
MLEC - KNTPF
27%
Poorly correlated
-3.99%
KNSA - KNTPF
20%
Poorly correlated
+0.73%
UNCY - KNTPF
20%
Poorly correlated
-2.94%
RLFTY - KNTPF
20%
Poorly correlated
N/A
BCTX - KNTPF
9%
Poorly correlated
+2.80%
More